The main market opportunity lies in providing expertise and solutions for navigating the complex landscape of pharmacovigilance obligations in global licensing agreements, ensuring compliance, and ...

The main market opportunity lies in providing comprehensive training programs to help pharmaceutical companies comply with stringent EU pharmacovigilance regulations, ensuring all staff are ...

Before the drug is introduced for general use in the market called Pre-market research and development stage and, once the drug is introduced into the market called post-market real-world use stage.

The study, titled “GenAI-Powered Framework for Reliable Sentiment Labeling in Drug Safety Monitoring,” published in Applied ...

Pharmacovigilance courses as equip healthcare professionals with the knowledge and skills needed to effectively monitor and evaluate the safety profile of medications. Participants learn about adverse ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in pharmacovigilance, the science dedicated to ensuring drug safety. Pharmacovigilance ...

Pharmaceutical drugs are a valuable part of patient care throughout the world. For doctors to adequately care for their patients, drug safety must be monitored and reported from initial testing to ...

In the past, the primary role of the Affiliate office was to liaise with local health authorities. However with the harmonisation and globalisation of pharmacovigilance regulations, its role has been ...

Webinar Date/Time: Tue, Jan 30, 2024 10:00 AM EST | 9:00 AM CT | 3:00 PM GMT | 4:00 PM CET This webinar will delve into how organizations can foster a culture that simultaneously encourages innovative ...

Experts debate the practice’s rise up the life sciences agenda. Pharmacovigilance’s influence has begun to encompass more than regulatory compliance, as can be seen by the number of trends identified ...

AI is transitioning from theory to operational use in pharmacovigilance, but adoption remains uneven. In this interview, Gary ...

Despite pharmacovigilance legislation being in place for nearly a decade, many companies are still struggling to fulfill obligations. It is now eight years since current European Union ...